Thursday, February 12, 2026 | 02:51 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sanket Koul

Sanket Koul

Sanket Koul

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Email

Page 20 - Sanket Koul

After JNU, Jamia suspends MoU with Turkish institutions citing security

Jamia Millia Islamia suspends all MoUs with institutions linked to Turkiye, joining JNU and CSJM in response to growing concerns over national security and diplomacy

After JNU, Jamia suspends MoU with Turkish institutions citing security
Updated On : 13 Oct 2025 | 11:03 PM IST

IHH's move to seek increased damages may not affect Fortis expansion plans

Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over stalled open offer and regulatory hurdles

IHH's move to seek increased damages may not affect Fortis expansion plans
Updated On : 21 May 2025 | 10:15 PM IST

Hypertension, anti allergy meds among 196 drugs flagged by CDSCO as NSQ

Monthly CDSCO alert identifies 196 batches of drugs as not of standard quality and flags one Deca-Durabolin injection as spurious and under investigation

Hypertension, anti allergy meds among 196 drugs flagged by CDSCO as NSQ
Updated On : 21 May 2025 | 6:09 PM IST

Fortis Healthcare Q4 profit drops 7% on rise in quarterly expenses

The hospital chain's revenue rose 12.4% to Rs 2,007 crore in Q4 FY25 driven by hospital and diagnostics segments, but higher expenses and impairments hit net profit

Fortis Healthcare Q4 profit drops 7% on rise in quarterly expenses
Updated On : 21 May 2025 | 12:05 AM IST

India logs 164 new Covid-19 cases in one week, active cases cross 250

India records 164 new Covid-19 cases between May 12 and 19, with Kerala, Tamil Nadu and Maharashtra reporting most cases; officials say symptoms remain mild

India logs 164 new Covid-19 cases in one week, active cases cross 250
Updated On : 20 May 2025 | 10:00 PM IST

IHH subsidiary seeks Rs 11,800 cr damages from Daiichi over Fortis deal

IHH arm NTK raises damages claim against Daiichi Sankyo to Rs 11,800 crore, alleging obstruction of Fortis Healthcare acquisition via stalled open offer

IHH subsidiary seeks Rs 11,800 cr damages from Daiichi over Fortis deal
Updated On : 20 May 2025 | 9:27 PM IST

DLF records highest-ever sales in FY25 on super luxury housing boom

Projects like The Dahlias and Privana West fuelled DLF's FY25 sales to a record Rs 21,223 crore, with strong demand from domestic buyers and NRIs

DLF records highest-ever sales in FY25 on super luxury housing boom
Updated On : 20 May 2025 | 8:55 PM IST

Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32%

Profit growth driven by higher occupancy, rising Arpob, international patient inflow and new bed additions across Lucknow, Dwarka and BLK Max facilities

Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32%
Updated On : 20 May 2025 | 4:57 PM IST

Lupin to boost complex generics in US, EU; eyes chronic growth in India

Lupin plans to expand complex generics in developed markets and grow its chronic drug portfolio in India, with over 200 product launches and M&A on the radar

Lupin to boost complex generics in US, EU; eyes chronic growth in India
Updated On : 19 May 2025 | 10:57 PM IST
Bhutani Infra, Yashoda Hospitals in ₹1,000 cr JV for Noida project
Updated On : 19 May 2025 | 10:31 PM IST

DLF Q4FY25 results: Net profit rises 39% to ₹1,282 crore; revenue up 46%

DLF posts robust Q4FY25 results with 39% rise in profit and 46% growth in revenue, driven by record sales from luxury projects and steady rental performance

DLF Q4FY25 results: Net profit rises 39% to ₹1,282 crore; revenue up 46%
Updated On : 19 May 2025 | 9:34 PM IST

Govt holds review meetings to monitor Covid-19 situation in India

Govt says Covid-19 situation remains under control despite a minor uptick in cases, amid rising infections in Singapore and Hong Kong attributed to Omicron subvariants

Govt holds review meetings to monitor Covid-19 situation in India
Updated On : 19 May 2025 | 9:02 PM IST

Covid-19 spike in Hong Kong, Singapore not yet a concern for India: Experts

Doctors advise calm as India sees just 58 new Covid-19 cases amid a rise in HK and Singapore; experts highlight low hospitalisation and no serious strain currently

Covid-19 spike in Hong Kong, Singapore not yet a concern for India: Experts
Updated On : 18 May 2025 | 11:32 PM IST

Capacit'e eyes Middle East market after Maldives foray, cites growth

Data centres and hospitals are key growth drivers for EPC firm Capacit'e Infraprojects as it enters global markets after its first international project in Maldives

Capacit'e eyes Middle East market after Maldives foray, cites growth
Updated On : 18 May 2025 | 8:56 PM IST

Signature Global may launch NCR projects worth ₹17,000 crore in FY26

Firm looks to stay in its core mid-size project segment

Signature Global may launch NCR projects worth ₹17,000 crore in FY26
Updated On : 16 May 2025 | 10:13 PM IST

Medanta Q4 PAT falls 20%, revenue rises 15% on strong patient volume

Global Health reports Q4FY25 PAT drop to ₹101.4 crore on one-time expense; revenue up 15% to ₹931.2 crore; expansion plans include 550-bed Noida facility by FY26

Medanta Q4 PAT falls 20%, revenue rises 15% on strong patient volume
Updated On : 16 May 2025 | 7:30 PM IST

Signature Global Q4 results: Net profit rises 48%, revenue down 25%

Realty firm Signature Global saw a record ₹10,290 crore in FY25 pre-sales despite a Q4 revenue decline caused by project launch delays due to pending approvals

Signature Global Q4 results: Net profit rises 48%, revenue down 25%
Updated On : 15 May 2025 | 11:01 PM IST

Lupin Q4 results: Net profit zooms by 112% to ₹782 cr, revenue up 14%

The company's revenue from operations rose 14.2 per cent Y-o-Y to ₹5,671 crore, from ₹4,961 crore in Q4FY24

Lupin Q4 results: Net profit zooms by 112% to ₹782 cr, revenue up 14%
Updated On : 15 May 2025 | 12:45 AM IST

Sanofi India Q4 results: Profit falls 12.5% to ₹119.5 cr, revenue up 4.9%

Sanofi India's Q4FY25 profit declined 12.5% Y-o-Y to ₹119.5 crore, while revenue rose 4.9%; operating profit improved 27% on better efficiency, says CFO

Sanofi India Q4 results: Profit falls 12.5% to ₹119.5 cr, revenue up 4.9%
Updated On : 14 May 2025 | 8:05 PM IST

PM Modi calls for scaling up early detection to eliminate TB by 2025

India accounts for 26 per cent of global TB burden; PM highlights technology use, infrastructure expansion and targeted outreach as key to meeting 2025 goal

PM Modi calls for scaling up early detection to eliminate TB by 2025
Updated On : 14 May 2025 | 8:52 AM IST